FFA
CYTK icon

Farther Finance Advisors’s Cytokinetics CYTK Stock Holding History

Farther Finance Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58K Sell
678
-431
-39% -$30.9K ﹤0.01% 3130
2026
Q1 		$73.9K Buy
1,109
+2
+0.2% +$127 ﹤0.01% 2733
2025
Q4 		$70.3K Sell
1,107
-8
-0.7% -$498 ﹤0.01% 2576
2025
Q3 		$61.3K Buy
1,115
+453
+68% +$18.7K ﹤0.01% 2330
2025
Q2 		$21.9K Sell
662
-216
-25% -$7.51K ﹤0.01% 2626
2025
Q1 		$32.9K Sell
878
-137
-13% -$6.3K ﹤0.01% 2119
2024
Q4 		$47.7K Sell
1,015
-64
-6% -$3.32K ﹤0.01% 1680
2024
Q3 		$57K Sell
1,079
-181
-14% -$10.1K ﹤0.01% 1580
2024
Q2 		$68.9K Buy
1,260
+24
+2% +$1.45K ﹤0.01% 1274
2024
Q1 		$90.3K Buy
1,236
+65
+6% +$5.03K 0.01% 976
2023
Q4 		$97.8K Sell
1,171
-133
-10% -$4.82K 0.01% 810
2023
Q3 		$38.4K Buy
1,304
+52
+4% +$1.73K 0.01% 860
2023
Q2 		$40.8K Sell
1,252
-476
-28% -$17.6K 0.01% 737
2023
Q1 		$60.8K Buy
+1,728
New +$70.5K 0.02% 548

Other funds holding CYTK

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Farther Finance Advisors's CYTK Position: Q2 2026 in Review

Farther Finance Advisors reduced its Cytokinetics (CYTK) stake by 39% in Q2 2026, selling an estimated $30.9K and leaving 678 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #3130.

Farther Finance Advisors first reported a position in CYTK in Q1 2023 and has held it in 14 quarters since. The position peaked at $97.8K in Q4 2023. 35 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Farther Finance Advisors held 678 shares of Cytokinetics worth $58K as of Q2 2026.
  • Farther Finance Advisors sold 431 Cytokinetics shares in Q2 2026, an estimated $30.9K.
  • Cytokinetics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3130 holding.
  • Farther Finance Advisors first reported a position in Cytokinetics in Q1 2023 and has held it in 14 quarters since.
  • Farther Finance Advisors's Cytokinetics position peaked at $97.8K in Q4 2023.
  • 35 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.